Evaluation of Top-selling Biotechnological Medicine from 2003 to 2016 in Turkey

Journal Title: HASEKİ TIP BÜLTENİ - Year 2019, Vol 57, Issue 2

Abstract

Aim: The top 100 medicines having the highest annual average sales between the years 2006 and 2015, had exceeded one-fourth of the total pharmaceutical market’s value in these years. We aimed to study the status of biotechnological medicines among these medicines and evaluate the effects of policy interventions on their sales. Methods: Sales of all medicines on an annual average value basis were calculated. The top 100 medicines with the highest annual average sales were included in the study. Time series analysis has been used for prospective estimations. Results: Up to 2007 biotechnological medicines had not been in the top ten medicines; it increased dramatically after 2007 and in 2016, the sales of biotechnological medicines reached to 82% in top 10 sales in Turkey. On the other hand the number of biotechnological medicines among the top 100 medicines was 4 in 2003; it reached to 27 in 2016. However the number of biotechnological medicines in the top 10 medicines was 1 in 2003 and it reached to 8 in 2016. Conclusion: The shares of biotechnological medicines in both the total pharmaceutical market and in the group of medicines with high sales are increasing every year. New policies should be developed to ensure the stability of the reimbursement system.

Authors and Affiliations

Elif Hilal Vural, Esra Şafak Yılmaz, Güven Bektemür, İsmail Mert Vural, Banu Bayar, Hakkı Gürsöz

Keywords

Related Articles

Monitoring and Transfusion Nursing Practices with Electronic Record in Blood Transfusion Process Management

Aim: We aimed to evaluate the effects of the application of the electronic blood tracking system and transfusion nursing on the transfusion process. Methods: Blood transfusion tracking forms were included in the hospital...

Comparison of Ketamine, Fentanyl and Remifentanyl in Terms of Sedoanalgesia for Colonoscopy: A Randomized Prospective Double-blind Study

Aim: The aim of this study was to compare the effects of fentanyl, remifentanyl and ketamine applied for analgesia during colonoscopy on hemodynamics and sedo-analgesia quality Methods: A total of 81 patients, who were s...

Isolated Unilateral Temporalis Muscle Hypertrophy: A Case Report and Review of the Literature

Isolated unilateral temporalis muscle hypertrophy is a very rare pathology that nine cases have been reported to date. We report the 10th case of this rare condition and a review of the literature. Swelling of the mastic...

Safety of Microstream Capnography Monitoring in Patients Under Sedation for Colonoscopy

Aim: The purpose of this study was to investigate the effectiveness of micro stream capnography in early recognition of adverse events during sedation for colonoscopy. Methods: This prospective randomized study was perfo...

Adnexal Torsion: Difficulty in Diagnosis and Management

Aim: To investigate both the diagnostic value of Doppler-ultrasonography and factors influencing surgical intervention in patients with adnexal torsion (AT). Methods: We retrospectively examined medical records of 66 wom...

Download PDF file
  • EP ID EP541738
  • DOI 10.4274/haseki.galenos.2018.4566
  • Views 57
  • Downloads 0

How To Cite

Elif Hilal Vural, Esra Şafak Yılmaz, Güven Bektemür, İsmail Mert Vural, Banu Bayar, Hakkı Gürsöz (2019). Evaluation of Top-selling Biotechnological Medicine from 2003 to 2016 in Turkey. HASEKİ TIP BÜLTENİ, 57(2), 108-113. https://europub.co.uk/articles/-A-541738